GRN and amyotrophic lateral sclerosis: In humans, mutations in PGRN are associated with familial frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) with pathology of transactive response DNA-binding protein 43 kD (TDP43)8–12.